Publications

Export 7 results:
Author Title Type [ Year(Desc)]
Filters: Author is Cervantes, Pablo  [Clear All Filters]
2015
Parikh SV, Hawke LD, Velyvis V, Zaretsky A, Beaulieu S, Patelis-Siotis I, MacQueen G, L Young T, Yatham LN, Cervantes P.  2015.  Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder.. Bipolar Disord. 17(1):86-96.
2016
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM et al..  2016.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.. Lancet. 387(10023):1085-93.
Hou L, Bergen SE, Akula N, Song J, Hultman CM, Landen M, Adli M, Alda M, Ardau R, Arias B et al..  2016.  Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.. Hum Mol Genet. 25(15):3383-3394.
2018
Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K et al..  2018.  Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.. Front Psychiatry. 9:207.
Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu Y-H, Shekhtman T et al..  2018.  Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.. JAMA Psychiatry. 75(1):65-74.
Soh JFotso, Torres-Platas SG, Beaulieu S, Mantere O, Platt R, Mucsi I, Saury S, Renaud S, Levinson A, Andreazza AC et al..  2018.  Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.. BMC Psychiatry. 18(1):227.
Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, Adli M, Adorjan K, Akula N, Alda M et al..  2018.  Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.. Bipolar Disord.